These results suggest that ATF6-mediated EGF expression in SCCs plays an important role in angiogenesis-stimulating activities, resulting in a switch from SCCs to actively cycling cancer cells and eventually leading to tumor recurrence. This evidence concerns the gene EGF and neoplasm.